Engineered immune cells target deadly brain tumors in children

NCT ID NCT07680439

First seen Jul 02, 2026 · Last updated Aug 05, 2026 · Updated 2 times

Summary

This study tests a new treatment called BCB-276 for children and young adults with diffuse intrinsic pontine glioma (DIPG), a rare and aggressive brain tumor. BCB-276 is made from a patient's own immune cells, which are modified in a lab to recognize and attack the cancer. The treatment is given directly into the fluid around the brain every two weeks for about 7-8 months. The goal is to see if it is safe and can help people live longer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
BCB-276 (a CAR T cell therapy made from the patient's own immune cells, targeting B7-H3)
What this could lead to
If successful, this could offer a new treatment option for DIPG, a rare and aggressive brain tumor with few effective therapies, potentially improving survival.
What could go wrong
This is an early-phase trial with a small number of participants. The therapy may cause serious side effects, and it is not yet known if it will improve survival compared to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULT CANCER PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Children's Healthcare of Atlanta

    NOT_YET_RECRUITING

    Atlanta, Georgia, 30329, United States

    Contact Email: •••••@•••••

  • Children's Hospital Los Angeles

    NOT_YET_RECRUITING

    Los Angeles, California, 90027, United States

    Contact Email: •••••@•••••

  • Children's Hospital of Philadelphia

    NOT_YET_RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Lurie Children's Hospital

    NOT_YET_RECRUITING

    Chicago, Illinois, 60611, United States

  • Nationwide Children's Hospital

    NOT_YET_RECRUITING

    Columbus, Ohio, 43205, United States

  • Seattle Children's Hospital

    RECRUITING

    Seattle, Washington, 98105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.